News

Karen Kozek

Vessi Medical’s surface cryoablation therapy for bladder cancer demonstrates successful animal trial results

Vessi’s bladder-specific cryoablation technology may eliminate problems often reported with transurethral resection of bladder tumor (TURBT), today’s first line of treatment.

The Trendlines Group Trendletter January 2019

… Welcome 3 new medical portfolio companies … ViAqua closes investment round … ZygoFix receives Horizon 2020 grant … CoreBone wins in China …

SEEDS Capital names Trendlines a co-investment partner

Trendlines new Singapore-based venture fund has been appointed as one of the partners under the SEEDS Capital Startup SG Equity scheme.

Leviticus Cardio Awarded R&D Grant from BIRD Foundation

Leviticus Cardio and Jarvik Heart were awarded an R&D grant from the prestigious Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation.

Trendlines to launch Singapore-based agrifood tech innovation center

We plan to raise a $40 million venture fund to support the center’s investment activity.

AgFunder features ViAqua

AgFunder featured exclusive coverage of ViAqua’s investment from Singapore-based VisVires New Protein.

The Trendlines Group Trendletter December 2018

… Marking 3 years on the Singapore Exchange … Welcome 3 new companies … ZygoFix starts FIH … Leviticus achieves significant preclinical milestone … Saturas enters new market  …

NextInsight: Patients recovering well after scoliosis treatment with ApiFix

The procedures in Singapore with the ApiFix system “went exceptionally well and significant curve correction was achieved … .”

Successful first in human for ZygoFix’s spinal facet joint fixation system

ZygoFix announced the successful start of a first in human clinical study for its zLOCK spinal facet joint fixation system.

IntraFish highlights the BioFishency filter system

IntraFish featured BioFishency’s  “plug-and-play filter system” for aquaculture.